Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Subretinal Macugen® for Neovascular Age-Related Macular Degeneration

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009 by Klinikum Ludwigshafen.
Recruitment status was  Recruiting
Information provided by:
Klinikum Ludwigshafen Identifier:
First received: November 7, 2008
Last updated: September 26, 2011
Last verified: July 2009
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)